CORIN
Basic information
Region (hg38): 4:47593999-47838106
Links
Phenotypes
GenCC
Source:
- preeclampsia/eclampsia 5 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Preeclampsia/eclampsia 5; Cardiomyopathy, familial hypertrophic, 30, atrial | AD/AR | Cardiovascular; Obstetric | Individuals with Cardiomyopathy, familial hypertrophic, 30, atrial may manifest with cardiovascular complications, including hypertension, cardiomyopathy, and arrhthymia, and awareness may allow early identification and medical management; Individuals with Preeclampsia/eclampsia may be at high risk for pregnancy complications such as preeclampsia/eclampsia, and thus preconception planning, surveillance during pregnancy (eg, including related to proteinuria, hypertension, liver function, and hematologic parameters), as well as delivery planning may be beneficial in order to decrease associated morbidity and mortality | Cardiovascular; Obstetric | 22437503; 37913506 |
ClinVar
This is a list of variants' phenotypes submitted to
- Cardiomyopathy, familial hypertrophic, 30, atrial (1 variants)
- Cardiomyopathy;Atrial fibrillation;Myocardial fibrosis;Hypertensive disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CORIN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 85 | 96 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 2 | 6 | |||
non coding | 3 | |||||
Total | 1 | 0 | 85 | 11 | 9 |
Highest pathogenic variant AF is 0.0000265
Variants in CORIN
This is a list of pathogenic ClinVar variants found in the CORIN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-47595732-G-C | Inborn genetic diseases | Uncertain significance (Sep 22, 2023) | ||
4-47595743-A-T | Inborn genetic diseases | Uncertain significance (May 02, 2024) | ||
4-47595782-A-C | Inborn genetic diseases | Uncertain significance (Oct 28, 2023) | ||
4-47595795-C-T | Inborn genetic diseases | Uncertain significance (Jan 19, 2022) | ||
4-47595861-G-A | Inborn genetic diseases | Uncertain significance (Jul 27, 2022) | ||
4-47595884-A-T | Inborn genetic diseases | Uncertain significance (Aug 04, 2023) | ||
4-47595894-C-A | Inborn genetic diseases | Uncertain significance (Aug 08, 2023) | ||
4-47595903-C-T | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
4-47600233-C-T | Inborn genetic diseases | Uncertain significance (Jul 25, 2023) | ||
4-47600242-T-C | Inborn genetic diseases | Uncertain significance (Oct 05, 2022) | ||
4-47600258-T-C | Inborn genetic diseases | Uncertain significance (Mar 31, 2024) | ||
4-47600314-A-G | Inborn genetic diseases | Uncertain significance (Apr 22, 2022) | ||
4-47600317-C-T | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
4-47600318-G-A | Inborn genetic diseases | Uncertain significance (Oct 06, 2023) | ||
4-47600350-GA-G | CORIN-related disorder | Likely benign (Oct 28, 2019) | ||
4-47603404-G-T | Benign (Dec 31, 2019) | |||
4-47603446-C-G | Inborn genetic diseases | Uncertain significance (Dec 08, 2024) | ||
4-47603448-C-T | Inborn genetic diseases | Uncertain significance (Sep 26, 2023) | ||
4-47603522-A-G | Inborn genetic diseases | Uncertain significance (Nov 26, 2024) | ||
4-47603552-C-T | Inborn genetic diseases | Uncertain significance (Dec 28, 2023) | ||
4-47603592-G-A | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
4-47603611-T-A | Likely benign (Aug 03, 2017) | |||
4-47603628-T-A | Inborn genetic diseases | Uncertain significance (Jan 26, 2022) | ||
4-47603631-T-A | Inborn genetic diseases | Uncertain significance (Jun 16, 2023) | ||
4-47603651-A-C | Inborn genetic diseases | Uncertain significance (Aug 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CORIN | protein_coding | protein_coding | ENST00000273857 | 22 | 244109 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.51e-35 | 0.0000175 | 125145 | 0 | 603 | 125748 | 0.00240 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.167 | 608 | 597 | 1.02 | 0.0000323 | 6943 |
Missense in Polyphen | 252 | 255.4 | 0.98668 | 2938 | ||
Synonymous | 0.164 | 224 | 227 | 0.986 | 0.0000135 | 1871 |
Loss of Function | 0.134 | 53 | 54.1 | 0.980 | 0.00000245 | 667 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00821 | 0.00593 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0206 | 0.0205 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000629 | 0.000607 |
Middle Eastern | 0.0206 | 0.0205 |
South Asian | 0.000561 | 0.000555 |
Other | 0.00164 | 0.00163 |
dbNSFP
Source:
- Function
- FUNCTION: Serine-type endopeptidase involved in atrial natriuretic peptide hormone (NPPA) processing. Converts through proteolytic cleavage the non-functional propeptide NPPA into the active hormone, thereby regulating blood pressure in heart and promoting natriuresis, diuresis and vasodilation. Proteolytic cleavage of pro-NPPA also plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus. Also acts as a regulator of sodium reabsorption in kidney. May also process pro-NPPB the B-type natriuretic peptide.;
- Disease
- DISEASE: Pre-eclampsia/eclampsia 5 (PEE5) [MIM:614595]: A hypertensive disorder of pregnancy characterized by new hypertension (blood pressure 140/90 or greater) presenting after 20 weeks' gestation with clinically relevant proteinuria. It impacts 2 individuals, the mother and her child, both of whom can be severely affected. Preeclampsia is one of the causes of maternal mortality and morbidity worldwide. {ECO:0000269|PubMed:22437503}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Physiological factors;Myometrial Relaxation and Contraction Pathways;corticosteroids and cardioprotection;Cardiac conduction;Muscle contraction
(Consensus)
Intolerance Scores
- loftool
- 0.201
- rvis_EVS
- -0.15
- rvis_percentile_EVS
- 42.34
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- N
- hipred_score
- 0.167
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0322
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Corin
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; renal/urinary system phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of systemic arterial blood pressure by atrial natriuretic peptide;female pregnancy;regulation of blood pressure;peptide hormone processing;regulation of renal sodium excretion;regulation of cardiac conduction
- Cellular component
- extracellular region;plasma membrane;cell surface;actin cytoskeleton;integral component of membrane;nuclear body
- Molecular function
- serine-type endopeptidase activity